IPO Date: Sep 29 to Oct 1 2025
Listing Date: Oct 7 2025
1. Funding of capital expenditure requirements of our company towards the construction of Pharmaceutical API/ Intermediates and Chemicals manufacturing plant and purchase of machineries in MIDC – Shrirampur, Ahmednagar, Maharashtra;
2. Repayment/prepayment of all or certain of our borrowings availed of by our Company;
3. General corporate purposes.
A/1, 1st Floor Devraj Premises C H S L Goregaon (West)
Mumbai
Maharashtra
400062
9820917040
nvestors@vijaypdceutical.com
www.vijaypdceutical.com
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
In terms of the provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) as amended from time to time, Tipco Engineering India has informed that it enclosed a copy of the Press Release titled ‘TIPCO Engineering India Limited Reports Strong H1 FY27 Results; Total Income Up 47%, EBITDA Up 72% and PAT Up 92% YoY’. The same is also available on the website of the Company at https://tipcoengineering.com/investors.
The above information is a part of company’s filings submitted to BSE.
Sonata Softwar has informed that Sonata Software North America, Inc (‘SSNA’) and Sonata Software Solutions North America, Inc (formerly known as Quant Systems, Inc.) (‘SSSNA’), wholly owned subsidiaries of the Company, have entered into a settlement agreement with Srinivas Veeravelli, the former Promoter of SSSNA, related to his employment with SSSNA and subsequent departure. The agreement concludes all obligations arising from the said Employment Agreement and Stock Purchase Agreement executed between SSNA, SSSNA, and Srinivas Veeravelli (‘SPA’), including amended agreements thereto. The total amount as final settlement in favour of SSNA and SSSNA is US $ 5.25 million along with the release of the balance deferred payment obligations of SSNA under the amended SPA dated 18th May, 2025 which had been provided for in the books of accounts. The value of the settlement agreement between Srinivas Veeravelli, SSNA, and SSSNA crosses the materiality thresholds of the Company under Regulation 30(4)(i)(c) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (‘SEBI LODR’). The information required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 are attached as Annexure A.
Pursuant to Regulation 30 of the SEBI Listing Regulations, Meesho has informed that the Nomination and Remuneration Committee of the Board of Directors of the Company by way of a circular resolution passed on November 18, 2026, has approved the allotment of 7,20,608 equity shares of face value of Re. 1 each to the eligible employees, upon exercise of vested options under Company’s ESOP 2024 Plan. The said equity shares shall rank with existing equity shares of the Company in all respects. Pursuant to the above allotment, the issued, subscribed and paid-up equity share capital of the Company stands increased from Rs. 4,63,10,08,781 (comprising 4,63,10,08,781 equity shares of Re. 1/- each) to 4,63,17,29,389 (comprising of 4,63,17,29,389 equity shares of Re. 1 each). The above information will also be made available on the Company’s website at: https://investor.meesho.com/announcements.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The issue size of Vijaypd Ceutical Ltd. IPO is ₹19.25 - 0.00 crore.
The Vijaypd Ceutical Ltd. IPO opens for subscription on 2025-09-29 and closes on 2025-10-01.
The price range of Vijaypd Ceutical Ltd. IPO is ₹35.00 to ₹0.00.
The lot size of Vijaypd Ceutical Ltd. IPO is 8000 shares.
The registrar of Vijaypd Ceutical Ltd. IPO is K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.).
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.